1. Home
  2. RDHL vs MRIN Comparison

RDHL vs MRIN Comparison

Compare RDHL & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MRIN
  • Stock Information
  • Founded
  • RDHL 2009
  • MRIN 2006
  • Country
  • RDHL Israel
  • MRIN United States
  • Employees
  • RDHL N/A
  • MRIN N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MRIN EDP Services
  • Sector
  • RDHL Health Care
  • MRIN Technology
  • Exchange
  • RDHL Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • RDHL 8.2M
  • MRIN 6.7M
  • IPO Year
  • RDHL N/A
  • MRIN 2013
  • Fundamental
  • Price
  • RDHL $5.85
  • MRIN $2.09
  • Analyst Decision
  • RDHL
  • MRIN
  • Analyst Count
  • RDHL 0
  • MRIN 0
  • Target Price
  • RDHL N/A
  • MRIN N/A
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • MRIN 16.8K
  • Earning Date
  • RDHL 08-29-2024
  • MRIN 02-20-2025
  • Dividend Yield
  • RDHL N/A
  • MRIN N/A
  • EPS Growth
  • RDHL N/A
  • MRIN N/A
  • EPS
  • RDHL N/A
  • MRIN N/A
  • Revenue
  • RDHL $3,707,000.00
  • MRIN $16,707,999.00
  • Revenue This Year
  • RDHL $224.90
  • MRIN N/A
  • Revenue Next Year
  • RDHL $82.69
  • MRIN N/A
  • P/E Ratio
  • RDHL N/A
  • MRIN N/A
  • Revenue Growth
  • RDHL N/A
  • MRIN N/A
  • 52 Week Low
  • RDHL $5.41
  • MRIN $1.44
  • 52 Week High
  • RDHL $20.28
  • MRIN $5.46
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • MRIN 51.22
  • Support Level
  • RDHL $5.80
  • MRIN $1.96
  • Resistance Level
  • RDHL $6.26
  • MRIN $2.48
  • Average True Range (ATR)
  • RDHL 0.31
  • MRIN 0.14
  • MACD
  • RDHL 0.01
  • MRIN 0.00
  • Stochastic Oscillator
  • RDHL 19.33
  • MRIN 25.06

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: